Celavie Biosciences to Present at April 2020 Virtual Investor Summit

A live webcast of the presentation will be available here. Following the conference, an archived version of the webcast will be available under the News section of the Company’s website.

Presentation Details
Date: Thursday, April 23, 2020
Time: 1:00pm ET
Webcast link: https://bit.ly/2K6GXBH

About the Virtual Investor Summit
The April 2020 Virtual Investor Summit will take place on April 22^nd and 23^rd from 10:00am – 3:00pm ET on both days. The event will feature presentations from public and private companies in multiple industries including life sciences/biotech, infrastructure and transportation. As part of the event, management teams will present a live audio webcast accompanied by a slide presentation and be available to participate in virtual Q&A sessions immediately following their presentation. Investors, media and interested parties can access the event schedule and individual company webcast details at the event website, virtualinvestorsummit.com.

About Celavie Biosciences
Celavie Biosciences is a privately-held company whose mission is to improve lives and restore hope by advancing regenerative stem cell therapies for the treatment of Parkinson’s disease and other disorders of the central nervous system (CNS). The company develops undifferentiated, unmodified allogeneic pluripotent stem cell-based therapies, holds a strong IP portfolio, including 18 issued patents, and has an experienced management team blending expertise in concept and cell technology, product scalability and entrepreneurship. Celavet, a subsidiary, applies the same proprietary technologies for the treatment and prevention of serious veterinary diseases. More information is available at https://www.celavie.com/.  

View source version on businesswire.com: https://www.businesswire.com/news/home/20200414005843/en/